Market Cap | ₹54Cr |
ROE | -8.42% |
P/E Ratio(TTM) | -7.19 |
EPS(TTM) | -1.65 |
P/B Ratio | 0.75 |
Dividend Yield | 0.00% |
Industry P/E | 28.69 |
Book Value | 15.92 |
Debt to Equity | 1.89 |
Face Value | 10 |
Parent Organisation | Indrayani Biotech |
Managing Director | Mr. Kasiraman Sundar |
BSE Symbol | 526445 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
TTK Healthcare | NA (0.00%) | 26.99 | ||
Andrew Yule & Co | NA (0.00%) | 68.34 | ||
Bluspring Enterprises | NA (0.00%) | -8.79 | ||
Krishna Defence & Allied Industries | NA (0.00%) | 54.68 |